Skip to content

Efficacy of Theta-burst Stimulation in the treatment of women with Fibromyalgia

Efficacy of Intermitent Theta-burst Stimulation in the treatment of women with Fibromyalgia: a sham-controlled clinic trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-39kxqtn
Enrollment
Unknown
Registered
2025-09-08
Start date
2024-07-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibromyalgia

Interventions

This is a three-arm, double-blind, randomized controlled clinical trial. A total of 45 female participants with fibromyalgia will be included, divided into three groups of 15 each (Control, Experiment
E02.621.820

Sponsors

Hospital Universitário Pedro Ernesto da Universidade do Estado do Rio de Janeiro
Lead Sponsor
Hospital Universitário Pedro Ernesto da Universidade do Estado do Rio de Janeiro
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Fibromyalgia diagnosis; 18 to 60y; feminine gender; pain > or = 4 in the numeric evaluation scale

Exclusion criteria

Exclusion criteria: Pregnancy; cancer; obesity level 3; metalic prosthesis; pacemaker; convulsion historic

Design outcomes

Primary

MeasureTime frame
We believe that Theta-bust protocol of EMT is equivalent to the EMT protocol used for pain, showing similar results on reduction of pain intensity in patients with fibromyalgia

Secondary

MeasureTime frame
Theta-burst stimulation is expected to reduce pain interference scores, catastrophizing, and depressive symptoms in patients with fibromyalgia

Countries

Brazil

Contacts

Public ContactFlavio Flutt

Hospital Universitário Pedro Ernesto - UERJ

flavio_flutt@icloud.com+55 (21) 996322660

Outcome results

None listed

Source: REBEC (via WHO ICTRP)